Vaxfab Enterprises Completes Major Allotment of 2.04 Crore Warrants and 21.27 Lakh Equity Shares
Vaxfab Enterprises Limited has completed allotment of 2,04,04,372 fully convertible warrants at ₹21.02 per share to 50 investors on preferential basis, convertible within 18 months. Additionally, 21,27,689 equity shares were issued upon warrant conversion by 41 investors at the same price. The allotments increased the company's paid-up share capital to ₹10,52,76,890 comprising 1,05,27,689 equity shares. The Board also corrected previous typographical errors in warrant numbers during their January 12, 2026 meeting.

*this image is generated using AI for illustrative purposes only.
Vaxfab Enterprises Limited has completed a substantial capital raising initiative through the allotment of fully convertible warrants and equity shares, marking a significant milestone in the company's expansion plans. The Board of Directors approved these allotments during their meeting held on January 12, 2026.
Warrant Allotment Details
The company has allotted 2,04,04,372 fully convertible warrants to 50 investors through preferential allotment. Each warrant is convertible into equivalent fully paid-up equity shares within a maximum period of 18 months from the allotment date.
| Parameter: | Details |
|---|---|
| Total Warrants Allotted: | 2,04,04,372 |
| Issue Price: | ₹21.02 per warrant |
| Face Value: | ₹10.00 per share |
| Number of Investors: | 50 |
| Conversion Period: | Maximum 18 months |
| Allotment Type: | Preferential basis |
The warrant allotment includes major allocations to entities such as Sparkling Tradewing LLP (19,98,097 warrants), Balmukund Tradelink Private Limited (19,74,310 warrants), and Markand Tradeventure LLP (19,55,281 warrants). Individual investors also participated significantly, with allocations ranging from 47,574 to 7,13,606 warrants per investor.
Equity Share Conversion
Simultaneously, the company issued 21,27,689 equity shares upon conversion of existing warrants by 41 investors. These shares were allotted at the same price of ₹21.02 per share, representing the exercise of previously allotted warrants.
| Conversion Details: | Amount |
|---|---|
| Equity Shares Issued: | 21,27,689 |
| Conversion Price: | ₹21.02 per share |
| Total Consideration: | ₹4,47,24,022.78 |
| Number of Converting Investors: | 41 |
Notable conversions include Mitesh Dineshbhai Patel and Seema Miteshkumar Patel, who each converted 3,09,229 warrants, and Mita Hitesh Ajmera, who converted 2,37,874 warrants into equity shares.
Impact on Share Capital
Following these allotments, Vaxfab Enterprises' paid-up equity share capital has increased substantially. The company's capital structure has been strengthened through this fundraising exercise.
| Capital Structure: | Before | After |
|---|---|---|
| Paid-up Share Capital: | ₹8,40,00,000 (estimated) | ₹10,52,76,890 |
| Total Equity Shares: | 84,00,000 (estimated) | 1,05,27,689 |
| Face Value per Share: | ₹10.00 | ₹10.00 |
Regulatory Compliance and Corrections
The company also addressed typographical errors from its previous submission dated January 12, 2026. The corrected figures show 2,04,04,372 warrants allotted instead of the previously mentioned 2,04,04,371, and Ms. Hema Hardik Parikh's allocation was corrected to 1,90,294 warrants instead of 2,85,442.
All allotments comply with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The equity shares allotted upon warrant conversion rank pari-passu with existing equity shares of the company. The Board meeting commenced at 8:00 PM and concluded at 8:30 PM on January 12, 2026, with Managing Director Ravindra Ashokbhai Joshi overseeing the proceedings.
Historical Stock Returns for Vaxfab Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.09% | +10.26% | +31.29% | +153.83% | +307.58% | +14.34% |


































